AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation
AMPK activation inhibits cardiac hypertrophy. Here the authors show that this occurs independently of previously proposed mechanisms and that AMPK controls the phosphorylation of the aminotransferase GFAT, thereby preventing cardiac hypertrophy through the reduction of protein O-GlcNAcylation.
Guardado en:
Autores principales: | Roselle Gélinas, Florence Mailleux, Justine Dontaine, Laurent Bultot, Bénédicte Demeulder, Audrey Ginion, Evangelos P. Daskalopoulos, Hrag Esfahani, Emilie Dubois-Deruy, Benjamin Lauzier, Chantal Gauthier, Aaron K. Olson, Bertrand Bouchard, Christine Des Rosiers, Benoit Viollet, Kei Sakamoto, Jean-Luc Balligand, Jean-Louis Vanoverschelde, Christophe Beauloye, Sandrine Horman, Luc Bertrand |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/46a09b637dfb42aab34016e0737a3bb6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Role and Function of O-GlcNAcylation in Cancer
por: Jii Bum Lee, et al.
Publicado: (2021) -
O-GlcNAcylation links oncogenic signals and cancer epigenetics
por: Lidong Sun, et al.
Publicado: (2021) -
O-GlcNAcylation is required for B cell homeostasis and antibody responses
por: Jung-Lin Wu, et al.
Publicado: (2017) -
O-GlcNAcylation in Chronic Lymphocytic Leukemia and Other Blood Cancers
por: David E. Spaner, et al.
Publicado: (2021) -
O-GlcNAcylated p53 in the liver modulates hepatic glucose production
por: Maria J. Gonzalez-Rellan, et al.
Publicado: (2021)